-
1
-
-
0030246905
-
Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels
-
Clarkson P, Celermajer DS, Donald AE et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573-9.
-
(1996)
J Am Coll Cardiol
, vol.28
, pp. 573-579
-
-
Clarkson, P.1
Celermajer, D.S.2
Donald, A.E.3
-
2
-
-
0032431072
-
Endothelial dysfunction in diabetes mellitus
-
Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998;32(suppl 3):S54-S61.
-
(1998)
J Cardiovasc Pharmacol
, vol.32
, Issue.SUPPL. 3
-
-
Cosentino, F.1
Luscher, T.F.2
-
3
-
-
0027381832
-
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.[see comment]
-
Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.[see comment]. Circulation 1993;88:2510-16.
-
(1993)
Circulation
, vol.88
, pp. 2510-2516
-
-
Johnstone, M.T.1
Creager, S.J.2
Scales, K.M.3
Cusco, J.A.4
Lee, B.K.5
Creager, M.A.6
-
4
-
-
0026684462
-
Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus
-
McVeigh GE, Brennan GM, Johnston GD et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771-6.
-
(1992)
Diabetologia
, vol.35
, pp. 771-776
-
-
McVeigh, G.E.1
Brennan, G.M.2
Johnston, G.D.3
-
6
-
-
0024811687
-
Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM
-
Rendell M, Bergman T, O'Donnell G, Drobny E, Borgos J, Bonner RF. Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM. Diabetes 1989;38:819-24.
-
(1989)
Diabetes
, vol.38
, pp. 819-824
-
-
Rendell, M.1
Bergman, T.2
O'Donnell, G.3
Drobny, E.4
Borgos, J.5
Bonner, R.F.6
-
7
-
-
0031939017
-
Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration
-
Veves A, Akbari CM, Primavera J et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457-63.
-
(1998)
Diabetes
, vol.47
, pp. 457-463
-
-
Veves, A.1
Akbari, C.M.2
Primavera, J.3
-
9
-
-
0032878326
-
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes
-
Caballero AE, Arora S, Saouaf R et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999;48:1856-62.
-
(1999)
Diabetes
, vol.48
, pp. 1856-1862
-
-
Caballero, A.E.1
Arora, S.2
Saouaf, R.3
-
10
-
-
0035116150
-
Diabetes and endothelial dysfunction: A clinical perspective
-
Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001;22:36-52.
-
(2001)
Endocr Rev
, vol.22
, pp. 36-52
-
-
Calles-Escandon, J.1
Cipolla, M.2
-
11
-
-
33645054062
-
-
Kathiresan S, Gona P, Larson MG et al. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.[see comment][erratum appears in Circulation 2006 Apr 4;113(13):e680]. Circulation 2006;113:938-45.
-
Kathiresan S, Gona P, Larson MG et al. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.[see comment][erratum appears in Circulation 2006 Apr 4;113(13):e680]. Circulation 2006;113:938-45.
-
-
-
-
12
-
-
0032738220
-
Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria
-
Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care 1999;22:1865-70.
-
(1999)
Diabetes Care
, vol.22
, pp. 1865-1870
-
-
Lim, S.C.1
Caballero, A.E.2
Smakowski, P.3
LoGerfo, F.W.4
Horton, E.S.5
Veves, A.6
-
13
-
-
2142649221
-
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus
-
Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-86.
-
(2004)
JAMA
, vol.291
, pp. 1978-1986
-
-
Meigs, J.B.1
Hu, F.B.2
Rifai, N.3
Manson, J.E.4
-
14
-
-
33644764947
-
Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: The Framingham Offspring Study
-
Meigs JB, O'Donnell CJ, Tofler GH et al. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 2006;55:530-7.
-
(2006)
Diabetes
, vol.55
, pp. 530-537
-
-
Meigs, J.B.1
O'Donnell, C.J.2
Tofler, G.H.3
-
15
-
-
0346406983
-
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: The EURODIAB Prospective Complications Study
-
Schram MT, Chaturvedi N, Schalkwijk C et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2003;26:2165-73.
-
(2003)
Diabetes Care
, vol.26
, pp. 2165-2173
-
-
Schram, M.T.1
Chaturvedi, N.2
Schalkwijk, C.3
-
16
-
-
23944492556
-
Inflammation and endothelial dysfunction are associated with retinopathy: The Hoorn Study
-
van Hecke MV, Dekker JM, Nijpels G et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 2005;48:1300-06.
-
(2005)
Diabetologia
, vol.48
, pp. 1300-1306
-
-
van Hecke, M.V.1
Dekker, J.M.2
Nijpels, G.3
-
17
-
-
2942701875
-
Inflammation
-
atherosclerosis and implications for therapy, III-20-III-26
-
Paoletti R, Gotto AM Jr, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation 2004;109:III-20-III-26.
-
(2004)
Circulation
, vol.109
-
-
Paoletti, R.1
Gotto Jr, A.M.2
Hajjar, D.P.3
-
18
-
-
0038639229
-
Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus
-
Streja D, Cressey P, Rabkin SW. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. J Diabetes Complications 2003;17:120-7.
-
(2003)
J Diabetes Complications
, vol.17
, pp. 120-127
-
-
Streja, D.1
Cressey, P.2
Rabkin, S.W.3
-
19
-
-
0033791015
-
Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy
-
Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rasmussen B. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med 2000;17:644-9.
-
(2000)
Diabet Med
, vol.17
, pp. 644-649
-
-
Clausen, P.1
Jacobsen, P.2
Rossing, K.3
Jensen, J.S.4
Parving, H.H.5
Feldt-Rasmussen, B.6
-
20
-
-
0036039004
-
Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy
-
Guler S, Cakir B, Demirbas B et al. Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy. Horm Res 2002;58:67-70.
-
(2002)
Horm Res
, vol.58
, pp. 67-70
-
-
Guler, S.1
Cakir, B.2
Demirbas, B.3
-
21
-
-
0035231707
-
Plasma levels of soluble vascular adhesion molecule-1 and cholesterol oxidation product in type 2 diabetic patients with nephropathy
-
Murakami H, Tamasawa N, Matsui J, Yamato K, JingZhi G, Suda T. Plasma levels of soluble vascular adhesion molecule-1 and cholesterol oxidation product in type 2 diabetic patients with nephropathy. J Atheroscler Thromb 2001;8:21-4.
-
(2001)
J Atheroscler Thromb
, vol.8
, pp. 21-24
-
-
Murakami, H.1
Tamasawa, N.2
Matsui, J.3
Yamato, K.4
JingZhi, G.5
Suda, T.6
-
22
-
-
33749052752
-
PAI-1 and the metabolic syndrome: Links, causes, and consequences
-
Alessi M-C, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol 2006;26:2200-07.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2200-2207
-
-
Alessi, M.-C.1
Juhan-Vague, I.2
|